Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Documentation Practices in Laboratory Notebooks – V 2.0

Posted on By

Analytical Method Development: SOP for Documentation Practices in Laboratory Notebooks – V 2.0

Standard Operating Procedure for Documentation Practices in Laboratory Notebooks in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/396/2025
Supersedes SOP/AMD/396/2022
Page No. Page 1 of 14
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to establish clear guidelines for documenting scientific work, including observations, calculations, and results in laboratory notebooks

within the Analytical Method Development (AMD) department. This ensures data integrity, traceability, and compliance with current regulatory standards such as ALCOA+ and Good Laboratory Practices (GLP).

2. Scope

This SOP applies to all analysts, scientists, and contract personnel working in the AMD laboratory who are responsible for generating, recording, or reviewing experimental data and activities in laboratory notebooks (paper or electronic).

3. Responsibilities

  • Analysts: Record all experimental work in a clear, legible, and chronological manner.
  • Supervisors/Group Leaders: Review and sign completed entries and ensure timely documentation practices are followed.
  • QA Personnel: Conduct periodic audits to ensure notebooks meet compliance and data integrity requirements.
See also  Analytical Method Development: SOP for Qualification of Reference Standards - V 2.0

4. Accountability

The Head of AMD is accountable for implementation, training, and adherence to documentation practices outlined in this SOP. QA Head is accountable for oversight and periodic review of documentation compliance.

5. Procedure

5.1 Notebook Allocation and Identification

  1. Each analyst will be assigned a uniquely numbered laboratory notebook.
  2. Record the following on the front cover:
    • Name of the Analyst
    • Department
    • Notebook Number
    • Start and End Date
  3. Issue and return of notebooks shall be tracked by the AMD Documentation Officer using Annexure-1.

5.2 Documentation Guidelines

  1. Write entries using a permanent ink pen (blue or black). Do not use pencils or erasable ink.
  2. Each page must be numbered sequentially and entries must be dated.
  3. Start each new experiment on a new page and provide a meaningful title.
  4. Record the objective, materials, procedure, observations, calculations, and results.
  5. Any graphs or printouts must be glued securely and signed across the pasted portion.

5.3 Corrections and Deviations

  1. Do not use correction fluid, erasers, or overwrite data.
  2. For corrections, strike through the incorrect entry with a single line, write the correct data next to it, and sign with date and initials.
  3. Deviations from procedure must be recorded and justified clearly.
See also  Analytical Method Development: Determination of Absorptivity Values - V 2.0

5.4 Signature and Review

  1. Each entry must be signed and dated by the analyst upon completion.
  2. Reviewer (Group Leader or Supervisor) must review and countersign within 5 working days.
  3. Comments by the reviewer must be dated and documented next to the reviewed content.

5.5 Closure of Notebook

  1. Upon completion, the notebook shall be closed with a summary and date of closure.
  2. QA or Documentation Officer shall verify completeness before archiving.
  3. Notebook status is updated in Annexure-1 record sheet.

5.6 Electronic Laboratory Notebooks (ELN)

  1. If used, ELNs must be validated systems compliant with 21 CFR Part 11.
  2. User access control, audit trails, and backup mechanisms must be enabled.
  3. Follow same documentation principles as physical notebooks.

6. Abbreviations

  • AMD: Analytical Method Development
  • ALCOA+: Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available
  • ELN: Electronic Laboratory Notebook
  • GLP: Good Laboratory Practices
See also  Analytical Method Development: SOP for Method to Determine Phase Separation in Gels - V 2.0

7. Documents

  1. Notebook Issue and Return Register – Annexure-1
  2. Notebook Review Checklist – Annexure-2

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 11 – Electronic Records, Electronic Signatures
  • WHO TRS 996 Annex 5 – Guidance on Good Data and Record Management Practices

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Sneha Mehta Rajiv Sharma Dr. Harshita Goyal
Designation AMD Analyst QA Reviewer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Notebook Issue and Return Register

Notebook No. Issued To Issue Date Return Date Remarks
AMD-LNB-0052 Sneha Mehta 01/03/2025 30/05/2025 Archived

Annexure-2: Notebook Review Checklist

Checklist Point Status (Yes/No) Reviewer Comments
Pages numbered and dated Yes Consistent
No correction fluid used Yes Compliant
Entries reviewed in time Yes Within 5 days

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Included ELN guidelines and expanded correction procedures Data Integrity Initiative Dr. Harshita Goyal
20/05/2022 1.0 Initial release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Qualification and Verification of Weighing Balances – V 2.0
Next Post: Analytical Method Development: SOP for Handling and Documentation of Raw Analytical Data – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version